Intended Use
For the qualitative determination of serum or plasma antibodies in humans, primarily IgM, to T. Cruzi using the ELISA technique.
Contents of Kit
1. Test Strips: Microwells containing Trypanosoma cruzi antigens - 96 test wells in a test strip holder.
2. Enzyme Conjugate: One (1) bottle containing 11 ml of anti-human IgM (μ chain)
3. Peroxidase (HRP) in a stabilizing buffer with Thimerosal.
4. Positive Control: One (1) vial containing 2 ml of a surrogate positive control.
5. Negative Control: One (1) vial containing 2 ml of diluted negative human sera in buffer with Thimerosal.
6. Chromogen: One (1) bottle containing 11 ml of the chromogen tetramethylbenzidine (TMB).
7. Wash Concentrate (20X): Two (2) bottles containing 25 ml of concentrated buffer and surfactant with Thimerosal.
8. Dilution Buffer: Two (2) bottles containing 30 ml of buffered protein solution with Thimerosal.
9. Stop Solution: One (1) bottle containing 11 ml of 1 M phosphoric acid.
General Description
Trypanosoma cruzi, commonly referred to as T. cruzi, is a single-celled parasitic organism that is the causative agent of Chagas disease. This disease is primarily found in Latin America but can also affect individuals in other regions due to globalization and increased travel.
T. cruzi is transmitted to humans through the feces of triatomine bugs, commonly known as "kissing bugs." When these bugs bite, they can leave behind infectious droppings that enter the body through the bite wound or mucous membranes. The disease can also be transmitted through blood transfusions, organ transplants, and from mother to child during pregnancy.
In the initial phase of Chagas disease, symptoms can include fever, fatigue, body aches, and swelling at the infection site. If left untreated, the disease can progress to a chronic phase, leading to serious complications such as heart disease, arrhythmias, and digestive issues.
T. cruzi is a protozoan parasite belonging to the Trypanosomatidae family. It has a complex life cycle that includes various stages in both insect and mammalian hosts. Diagnosis of Chagas disease typically involves serological tests to detect specific antibodies or molecular methods to identify the parasite's DNA. Treatment can be challenging, particularly in the chronic phase, but medications like benznidazole and nifurtimox are available for acute cases.
Preventive measures focus on controlling the vector population and raising awareness about the transmission routes of the disease.
COA
Publication 
Loading ......
